New York, Global Influenza Vaccine Market report from Global Insight Services is the single authoritative source of intelligence on Influenza Vaccine Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Influenza vaccine is a vaccine that protects against infection by influenza viruses. There are two types of influenza vaccines: inactivated (killed) influenza vaccine and live attenuated influenza vaccine (LAIV). Inactivated influenza vaccines are injected into the muscle, while LAIV is sprayed into the nose.
Request sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS21920/
Key Trends
The key trends in influenza vaccine technology are the development of new vaccine delivery methods, the use of new adjuvants to improve vaccine efficacy, and the use of new vaccine formulations to target specific populations.
One of the most promising new vaccine delivery methods is intradermal vaccination, which involves injecting the vaccine into the skin rather than the muscle. This method has been shown to be more effective than traditional intramuscular vaccination, and it is also less painful and easier to administer.
Another promising new trend is the use of adjuvants to improve vaccine efficacy. Adjuvants are substances that are added to vaccines to enhance their effectiveness. One of the most promising adjuvants is MF59, which has been shown to increase the efficacy of influenza vaccines by up to five-fold.
Finally, new vaccine formulations are being developed to target specific populations. For example, there is a new quadrivalent influenza vaccine that protects against four different strains of the virus, including the H1N1 strain. This vaccine is specifically designed for people who are at high risk of developing complications from influenza, such as pregnant women and young children.
Key Drivers
The key drivers of the influenza vaccine market are the increasing prevalence of influenza, the growing awareness about the disease, and the availability of effective vaccines. Influenza is a highly contagious disease that can cause severe illness, hospitalization, and death. Each year, an estimated 5 to 20 percent of the US population is infected with the influenza virus, and more than 200,000 people are hospitalized due to complications from the disease.
The influenza vaccine market is expected to grow due to the increasing prevalence of influenza and the growing awareness about the disease. The availability of effective vaccines is also a key driver of market growth. There are several different types of influenza vaccines available, including trivalent and quadrivalent vaccines. Trivalent vaccines protect against three different strains of the influenza virus, while quadrivalent vaccines protect against four different strains. The quadrivalent vaccines are more expensive than the trivalent vaccines, but they offer better protection against the flu.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS21920/
Market Segmentation
The influenza vaccine market is segmented into vaccine type, technology, age group, and region. By vaccine type, it is divided into quadrivalent and trivalent. By technology, it is classified into egg-based and cell-based. By age group, it is divided into pediatric and adult. By region, the market is classified into North America, Europe, Asia-Pacific and rest of the world.
Key Players
The key players in the Influenza Vaccine Market are Astrazeneca Plc (Astrazeneca), Biodiem, Csl Limited (Seqirus GmbH), Emergent Biosolutions, F. Hoffmann-La Roche Ltd., Gamma Vaccines Pty Ltd., Glaxosmithkline Plc, Merck & Co., Inc. (Merck Sharp & Dohme Corp.), Novartis Ag, Pfizer, Inc.
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS21920/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700